Observational Study
Copyright ©The Author(s) 2020.
World J Orthop. Sep 18, 2020; 11(9): 400-410
Published online Sep 18, 2020. doi: 10.5312/wjo.v11.i9.400
Figure 2
Figure 2 Percentage of patients with anti-platelet factor 4/heparin antibodies according to pharmacologic agent (P < 0. 05). LMWH: Low-molecular-weight heparin.